Ursolic Acid and Its Nanoparticles Are Potentiators of Oncolytic Measles Virotherapy against Breast Cancer Cells
Oncolytic viruses (OVs) and phytochemical ursolic acid (UA) are two efficacious therapeutic candidates in development against breast cancer, the deadliest women’s cancer worldwide. However, as single agents, OVs and UA have limited clinical efficacies. As a common strategy of enhancing monotherapeut...
Main Authors: | Ching-Hsuan Liu, Shu Hui Wong, Chen-Jei Tai, Cheng-Jeng Tai, Yu-Chi Pan, Hsue-Yin Hsu, Christopher D. Richardson, Liang-Tzung Lin |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-01-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/13/1/136 |
Similar Items
-
Measles to the Rescue: A Review of Oncolytic Measles Virus
by: Sarah Aref, et al.
Published: (2016-10-01) -
Advances in the design and development of oncolytic measles viruses
by: Hutzen B, et al.
Published: (2015-08-01) -
Prospects for Using Expression Patterns of Paramyxovirus Receptors as Biomarkers for Oncolytic Virotherapy
by: Olga V. Matveeva, et al.
Published: (2020-12-01) -
Editorial announcing PubMed indexing of Oncolytic Virotherapy
by: Farassati F
Published: (2017-02-01) -
Oncolytic Virotherapy in Glioma Tumors
by: Sergio Rius-Rocabert, et al.
Published: (2020-10-01)